Benitec Biopharma INC. (BNTC) — 10-Q Filings

All 10-Q filings from Benitec Biopharma INC.. Browse 4 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (4)

Benitec's Q1 Loss Widens 77% on Soaring G&A Costs — Nov 14, 2025 Risk: high
Benitec Biopharma Inc. reported a significant increase in net loss for the three months ended September 30, 2025, reaching $8.965 million, up from $5.059 millio
Benitec Biopharma Files Q3 10-Q Report — May 14, 2025 Risk: medium
Benitec Biopharma Inc. filed its Q3 10-Q report for the period ending March 31, 2025. The filing details financial information and operational updates for the c
Benitec Biopharma Files 10-Q for Period Ending Dec 31, 2024 — Feb 14, 2025 Risk: medium
Benitec Biopharma Inc. filed its 10-Q for the period ending December 31, 2024. The filing details financial performance and operational updates for the company.
Benitec Biopharma Inc. Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: medium
Benitec Biopharma Inc. (BNTC) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Benitec Biopharma Inc. filed a 10-Q report for the period ending Mar

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX